Paul Ehrlich Institute

The Paul Ehrlich Institute (German: Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, PEI) is a German federal agency, medical regulatory body and research institution for vaccines and biomedicines.

The institute is a WHO Collaborating Centre for quality assurance of blood products and in vitro diagnostic devices.

It is named for its founding director, the immunologist and Nobel Prize laureate Paul Ehrlich.

Ehrlich received numerous honours in Germany and was awarded the 1908 Nobel Prize in medicine.

The regulatory tasks of the Paul Ehrlich Institute include the marketing authorisation of particular groups of medicinal products and the approval of clinical trials.